Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06153459 · ClinicalTrials.gov registry record · NA
Cord Clamping Among Neonates With Congenital Heart Disease
A NA study of Congenital Heart Disease (CHD), sponsored by Carl Backes, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 20
- Study locations
NCT06153459 is a NA study of Congenital Heart Disease (CHD) that is actively recruiting participants, run by Carl Backes, MD. The registered enrollment target is 500 participants, above the 51-participant average among 3 other Congenital Heart Disease (CHD) trials with a reported enrollment target (880% higher). The trial reports 20 study locations across 15 states.
The verdict
NCT06153459, a NA study of Congenital Heart Disease (CHD), is actively recruiting participants, sponsored by Carl Backes, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this clinical trial is to compare 2 different timepoints for clamping the umbilical cord at birth for term-born infants with a prenatal diagnosis of congenital heart disease (CHD). The main questions it aims to answer are: * Does Delayed Cord Clamping at 120 seconds (DCC-120) or Delayed Cord Clamping at 30 seconds (DCC-30) after birth lead to better health outcomes? * Does DCC-120 seconds or DCC-30 seconds after birth lead to better neuromotor outcomes at 22-26 months of infant age (postnatal)? Participants will be asked to do the following: * Participate in either DCC-120 or DCC-30 at birth (randomized assignment). * Complete General Movements Assessment (GMA) at 3-4 months of infant age (postnatal), complete questionnaires / surveys at this time. * Complete questionnaires / surveys at 9-12 months of infant age (postnatal). * Complete Hammersmith Infant Neurological Examination (HINE), Developmental Assessment of Young Children 2 Edition (DAYC-2), and questionnaires / surveys at 22-26 months of infant age (postnatal). * Permit data collection from electronic medical records for both the mother and infant study participants. Investigators will compare DCC-120 vs. DCC-30 to see which approach is more beneficial to both the mother and baby with CHD.
Conditions Studied
Interventions
- PROCEDURE Umbilical Cord Clamping at ~30 seconds
- PROCEDURE Umbilical Cord Clamping at ~120 seconds
- PROCEDURE Umbilical Cord Milking
Study Locations (20)
California
- Cedars-Sinai Medical Center - Los Angeles
- Children's Hospital of Orange County - Orange
- Lucile Packard Children's Hospital Stanford - Palo Alto
- Sharp Mary Birch Hospital for Woman and Newborns - San Diego
Missouri
- The Children's Mercy Hospital - Kansas City
- SSM Health Cardinal Glennon Children's Hospital - St Louis
Texas
- Texas Children's Hospital - Houston
- University of Texas Health Science Center at San Antonio - San Antonio
Alabama
- Children's of Alabama - Birmingham
Florida
- UF Health Shands Children's Hospital - Gainesville
Maryland
- Johns Hopkins Children's Center - Baltimore
Mississippi
- Children's of Mississippi - Jackson
North Carolina
- Duke Children's Hospital & Health Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-12-19 |
| Est. Completion | 2030-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06153459
The ClinicalTrials.gov registry entry for NCT06153459 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 51-participant average among 3 other Congenital Heart Disease (CHD) trials with a reported enrollment target (880% higher). The listed sponsor is Carl Backes, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Heart Disease (CHD) appearing as the primary indexed condition, and to 3 interventions - of which Umbilical Cord Clamping at ~30 seconds is the first listed.
NCT06153459 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Missouri, Texas.
Frequently Asked Questions
What is clinical trial NCT06153459 about?
NCT06153459 is a clinical study titled "Cord Clamping Among Neonates With Congenital Heart Disease". The goal of this clinical trial is to compare 2 different timepoints for clamping the umbilical cord at birth for term-born infants with a prenatal diagnosis of congenital heart disease (CHD). The main questions it aims to answer are: * Does Delayed Cord Clamping at 120 seconds (DCC-120) or Delayed...
What is the current status of trial NCT06153459?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-12-19. Estimated completion is 2030-12.
What conditions does trial NCT06153459 study?
This clinical trial studies the following conditions: Congenital Heart Disease (CHD).
What interventions are being tested in trial NCT06153459?
The interventions under investigation include: Umbilical Cord Clamping at ~30 seconds (PROCEDURE), Umbilical Cord Clamping at ~120 seconds (PROCEDURE), Umbilical Cord Milking (PROCEDURE).
Who is sponsoring clinical trial NCT06153459?
This trial is sponsored by Carl Backes, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06153459 being conducted?
This trial has 20 study locations across Alabama, California, Florida, Maryland, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease (CHD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.